Valuation Check: Undervalued And Overvalued Stocks

April 17, 2026 at 03:24 UTC

5 min read
Visualization of stock market valuation gaps highlighting overvalued and undervalued major stocks

Key Points

  • New valuation work flags Intel (INTC) as sharply overvalued on DCF even after a 262% one-year surge
  • Johnson & Johnson (JNJ) screens as undervalued on both cash flow and earnings-based models despite litigation noise
  • Several growth and income names, including Ford (F) and Enphase, trade near or below intrinsic value estimates
  • Narrative-based fair values on Simply Wall St show wide valuation ranges for the same stocks

Mixed Valuation Signals Across Major Stocks

A series of new Simply Wall St analyses released on 17 April 2026 highlight sharply contrasting valuation signals across well-known companies, from technology and healthcare to autos and real estate. Using discounted cash flow (DCF), earnings and revenue multiples, and narrative-based fair values, the reports assess whether recent price moves leave upside or downside versus modeled intrinsic values.

Across the group, several stocks, including Johnson & Johnson (JNJ), Ford (F), Simon Property Group, Aurora Innovation, Oshkosh, Enphase Energy, Flow Traders and S&P Global (SPGI), currently screen as undervalued on at least one major metric, while Intel (INTC) stands out as materially overvalued on a DCF basis despite strong recent gains.

Intel Screens Rich On Cash Flow Metrics

Intel (INTC)’s valuation work focuses on a DCF model that uses a two-stage Free Cash Flow to Equity approach. With a latest twelve month free cash flow loss of about US$11.5 billion and projected free cash flow of US$4.3 billion in 2029, the model arrives at an intrinsic value estimate in the mid-teens per share.

That DCF outcome implies Intel is about 340.6% overvalued. The stock has rallied sharply, with reported returns of 11.0% over seven days, 55.5% over 30 days, 73.9% year to date and 261.9% over one year.

On a price-to-sales basis, however, Intel looks close to a proprietary "Fair Ratio". Its current P/S of 6.51x sits near the Semiconductor industry average of 6.17x and a Fair Ratio of 6.47x, leading Simply Wall St to describe the P/S-based result as "about right" despite the DCF premium.

Healthcare And Real Estate Names Flagged As Undervalued

Johnson & Johnson (JNJ) is assessed as undervalued on both DCF and P/E measures. A two-stage Free Cash Flow to Equity model, starting from about US$19.8 billion in latest twelve month free cash flow and projecting US$35.9 billion in 2030, yields an estimated intrinsic value around US$376.34 per share. Versus a current share price of US$234.54, this points to a 37.7% discount.

On earnings, Johnson & Johnson trades on a P/E of 26.85x, above both the Pharmaceuticals industry average of 16.76x and a peer average of 22.97x, but below a Fair Ratio of 29.77x. That gap leads Simply Wall St to categorize the stock as undervalued on this earnings-based metric as well.

In U.S. retail real estate, Simon Property Group has rallied strongly, returning 40.5% over one year and 127.2% over five years, to around US$201 a share. A DCF model based on approximately US$4.0 billion of last twelve month free cash flow and projected US$5.4 billion in 2030 produces an intrinsic value estimate of about US$284.37 per share, implying the stock is 29.2% undervalued. Its 14.14x P/E also sits below both industry and peer averages and a Fair Ratio of 22.48x.

Autos, Energy Tech And Financials: Modest Discounts

Ford Motor (F)’s DCF analysis suggests a relatively modest discount to intrinsic value. Using a two-stage Free Cash Flow to Equity model, with latest twelve month free cash flow of roughly US$12.5 billion and projected free cash flow of US$6.2 billion in 2035, Simply Wall St estimates intrinsic value at about US$13.66 per share. With the stock recently at US$12.44, Ford is judged around 8.9% undervalued.

Enphase Energy, after multi-year share price declines of 85.8% over three years and 80.1% over five years, trades near its DCF-based value but cheaper on earnings multiples. A DCF model using US$83.1 million of latest twelve month free cash flow and forecasts out to 2035 yields an intrinsic value near US$34.24 per share, versus a recent price of US$31.96, indicating roughly a 6.7% discount and "about right" valuation. Yet Enphase’s 24.5x P/E sits below both Semiconductor and peer averages and a Fair Ratio of 38.8x, leading the P/E-based view to categorize the stock as undervalued.

In capital markets, Flow Traders trades at €28.46 with a 9.28x P/E, below both the Capital Markets industry average of 18.46x and a Fair Ratio of 11.86x. An Excess Returns model that starts from book value of €19.93 per share and an average return on equity of 15.12% produces an intrinsic value near €41.07, suggesting the shares are 30.7% undervalued.

Narrative-Based Fair Values Shape Investor Debates

Several reports emphasize Simply Wall St’s "Narratives" feature, which links qualitative storylines to explicit valuation assumptions. For S&P Global (SPGI), a most popular narrative sets fair value at US$538.52 per share against a last close of US$436.79, framing the stock as 18.9% undervalued, although its current P/E of 28.9x matches peers and stands above a 17.5x Fair Ratio.

For Aurora Innovation, whose shares recently closed at US$5.17, the most followed narrative puts fair value around US$9.79, or 47.2% above the market price. That view leans on aggressive growth in driverless trucking and lower hardware costs, while acknowledging a small US$3 million revenue base and a US$816 million net loss. Oshkosh’s leading narrative places its fair value at US$172.67 versus a US$143.78 share price, implying 16.7% undervaluation and tying the case to electrification capabilities and multi-year government contracts.

Across these names, narrative fair values for Johnson Matthey also show tightening analyst expectations, with a trimmed fair value estimate of £21.13 and a cluster of price targets between £20 and £22. Analyst moves include Deutsche Bank (DBKd)’s Buy rating with a £21.20 target, Berenberg’s Buy at £22.50, and JPMorgan (JPM)’s Neutral at £20.00, after a series of target reductions.

Key Takeaways

  • Valuation outcomes differ sharply by method, with some stocks screening expensive on DCF but fairly priced on sales or earnings multiples
  • Several large, profitable companies, including Johnson & Johnson, Simon Property Group and Ford, are modeled as trading at discounts to intrinsic value
  • Narrative-based tools highlight how different revenue, margin and risk assumptions can justify wide fair value ranges for the same stock
  • Analyst target convergence, as seen in Johnson Matthey, can signal a more cautious but still supportive stance even when upside remains